Importantly, both transgene products, FVIII-SQ and FIX-R338L, demonstrate variable activity measurements in OSA versus chromogenic assay (CSA) determinants of factor activity that are reproducible across trials.144. This evidence concerns the gene F8 and obstructive sleep apnea syndrome.